ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

PD-1 or PD-L1 Blockade Adds Little to Combination of BRAF and MEK Inhibition in the Treatment of BRAF V600-Mutated Melanoma.

Margaret K Callahan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.